Logo image of WEST

WESTROCK COFFEE CO (WEST) Stock Fundamental Analysis

NASDAQ:WEST - Nasdaq - US96145W1036 - Common Stock - Currency: USD

5.86  -0.08 (-1.35%)

After market: 5.86 0 (0%)

Fundamental Rating

1

Taking everything into account, WEST scores 1 out of 10 in our fundamental rating. WEST was compared to 90 industry peers in the Food Products industry. Both the profitability and financial health of WEST have multiple concerns. WEST is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

WEST had negative earnings in the past year.
In the past year WEST has reported a negative cash flow from operations.
WEST had negative earnings in 4 of the past 5 years.
WEST had a negative operating cash flow in each of the past 5 years.
WEST Yearly Net Income VS EBIT VS OCF VS FCFWEST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -50M -100M -150M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.07%, WEST is doing worse than 70.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of -10.18%, WEST is doing worse than 70.00% of the companies in the same industry.
Industry RankSector Rank
ROA -4.07%
ROE -10.18%
ROIC N/A
ROA(3y)-3.91%
ROA(5y)N/A
ROE(3y)-11.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WEST Yearly ROA, ROE, ROICWEST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -50 -100

1.3 Margins

WEST has a Gross Margin of 16.27%. This is comparable to the rest of the industry: WEST outperforms 42.22% of its industry peers.
The Profit Margin and Operating Margin are not available for WEST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WEST Yearly Profit, Operating, Gross MarginsWEST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 5 -5 10 15

1

2. Health

2.1 Basic Checks

WEST does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for WEST. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
WEST Yearly Shares OutstandingWEST Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M
WEST Yearly Total Debt VS Total AssetsWEST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

WEST has an Altman-Z score of 1.22. This is a bad value and indicates that WEST is not financially healthy and even has some risk of bankruptcy.
WEST has a Altman-Z score of 1.22. This is in the lower half of the industry: WEST underperforms 66.67% of its industry peers.
WEST has a Debt/Equity ratio of 0.89. This is a neutral value indicating WEST is somewhat dependend on debt financing.
WEST's Debt to Equity ratio of 0.89 is on the low side compared to the rest of the industry. WEST is outperformed by 68.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 1.22
ROIC/WACCN/A
WACC11.03%
WEST Yearly LT Debt VS Equity VS FCFWEST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 200M -200M

2.3 Liquidity

A Current Ratio of 1.31 indicates that WEST should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.31, WEST is doing worse than 61.11% of the companies in the same industry.
WEST has a Quick Ratio of 1.31. This is a bad value and indicates that WEST is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.68, WEST is doing worse than 65.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.68
WEST Yearly Current Assets VS Current LiabilitesWEST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 100M 200M 300M

3

3. Growth

3.1 Past

WEST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -30.00%.
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.41%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.06%

3.2 Future

Based on estimates for the next years, WEST will show a very strong growth in Earnings Per Share. The EPS will grow by 33.91% on average per year.
The Revenue is expected to grow by 17.77% on average over the next years. This is quite good.
EPS Next Y42.12%
EPS Next 2Y44.63%
EPS Next 3Y33.91%
EPS Next 5YN/A
Revenue Next Year21.13%
Revenue Next 2Y17.9%
Revenue Next 3Y17.77%
Revenue Next 5YN/A

3.3 Evolution

WEST Yearly Revenue VS EstimatesWEST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 500M 1B
WEST Yearly EPS VS EstimatesWEST Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4 -0.6 -0.8

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WEST. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 71.81, which means the current valuation is very expensive for WEST.
WEST's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.46, WEST is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 71.81
WEST Price Earnings VS Forward Price EarningsWEST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

WEST's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. WEST is more expensive than 63.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 32.8
WEST Per share dataWEST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

WEST's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as WEST's earnings are expected to grow with 33.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.63%
EPS Next 3Y33.91%

0

5. Dividend

5.1 Amount

No dividends for WEST!.
Industry RankSector Rank
Dividend Yield N/A

WESTROCK COFFEE CO

NASDAQ:WEST (6/24/2025, 8:04:37 PM)

After market: 5.86 0 (0%)

5.86

-0.08 (-1.35%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners32.76%
Inst Owner Change-0.36%
Ins Owners5.97%
Ins Owner Change1.35%
Market Cap554.59M
Analysts83.64
Price Target10.81 (84.47%)
Short Float %18.91%
Short Ratio22.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3070.57%
Min EPS beat(2)-6671.48%
Max EPS beat(2)530.34%
EPS beat(4)1
Avg EPS beat(4)-2146.95%
Min EPS beat(4)-6671.48%
Max EPS beat(4)530.34%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.65%
Min Revenue beat(2)-8.54%
Max Revenue beat(2)-6.76%
Revenue beat(4)0
Avg Revenue beat(4)-7.83%
Min Revenue beat(4)-8.54%
Max Revenue beat(4)-6.76%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.92%
PT rev (3m)-3.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 71.81
P/S 0.52
P/FCF N/A
P/OCF N/A
P/B 1.43
P/tB 3.72
EV/EBITDA 32.8
EPS(TTM)-0.91
EYN/A
EPS(NY)0.08
Fwd EY1.39%
FCF(TTM)-2.42
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS11.31
BVpS4.1
TBVpS1.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.07%
ROE -10.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.27%
FCFM N/A
ROA(3y)-3.91%
ROA(5y)N/A
ROE(3y)-11.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA 15.65
Cap/Depr 619.86%
Cap/Sales 15.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.68
Altman-Z 1.22
F-Score2
WACC11.03%
ROIC/WACCN/A
Cap/Depr(3y)327.2%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.41%
EPS Next Y42.12%
EPS Next 2Y44.63%
EPS Next 3Y33.91%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.06%
Revenue Next Year21.13%
Revenue Next 2Y17.9%
Revenue Next 3Y17.77%
Revenue Next 5YN/A
EBIT growth 1Y-133.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1139.04%
EBIT Next 3Y219.97%
EBIT Next 5Y148.98%
FCF growth 1Y-90.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.13%
OCF growth 3YN/A
OCF growth 5YN/A